Use of Alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia
US7291595B2 · kind B2 · utility
2Cited by
2References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 19, 2005 |
| Grant date | Nov 6, 2007 |
| Priority date | — |
| Expiry date | Sep 19, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is based on the use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia, comprising the preparation of therapeutic concentrates of alpha-1 antitrypsin, in any form of administration tolerated by humans, the alpha-1 antitrypsin being obtained by purification of human plasma or being produced by recombinant or transgenic technology, with doses equal to or greater than 6 mg of alpha-1 antitrypsin per kg of body weight for a variable period of time.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.